Ercros, S.A. (LON:0M0E)

Market Cap	270.69M +20.0%
Revenue (ttm)	548.45M -5.9%
Net Income	-46.75M
EPS	-0.51
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,947
Average Volume	6,023
Open	3.415
Previous Close	3.425
Day's Range	3.415 - 3.440
52-Week Range	2.240 - 3.475
Beta	0.36
RSI	55.42
Earnings Date	Feb 27, 2026

About Ercros

Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. It also provides ...

• Industry: Industrial Inorganic Chemicals
• Founded: 1817
• Employees: 1,329
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0M0E

Financial Performance

In 2025, Ercros's revenue was 628.69 million, a decrease of -5.92% compared to the previous year's 668.22 million. Losses were -53.59 million, 359.7% more than in 2024.

Financial numbers in EUR